First National Corp Abb Vie Inc. Transaction History

First National Corp

$449 Million
Q3 2024

A detailed history of First National Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, First National Corp holds 6,936 shares of ABBV stock, worth $1.23 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

6,936

Previous 7,019 1.18%

Holding current value

$1.23 Million

Previous $1.2 Million 13.8%

% of portfolio

0.3%

Previous 0.29%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$163.84 - $199.33 $13,598 - $16,544	-83 Reduced 1.18%	6,936 $1.37 Million
Q2 2024 Jul 12, 2024	BUY	$154.79 - $180.76 $53,712 - $62,723	347 Added 5.2%	7,019 $1.2 Million
Q4 2023 Jan 18, 2024	BUY	$137.6 - $154.97 $6,192 - $6,973	45 Added 0.68%	6,672 $1.03 Million
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $7,420 - $9,234	56 Added 0.85%	6,627 $892,000
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $2,952 - $3,386	-22 Reduced 0.33%	6,571 $882,000
Q2 2022 Jul 18, 2022	BUY	$137.62 - $174.96 $2,752 - $3,499	20 Added 0.3%	6,593 $1.01 Million
Q1 2022 Apr 26, 2022	SELL	$131.98 - $163.75 $10,822 - $13,427	-82 Reduced 1.23%	6,573 $1.07 Million
Q4 2021 Jan 28, 2022	SELL	$107.43 - $135.93 $214 - $271	-2 Reduced 0.03%	6,655 $901,000
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $17,662 - $20,049	166 Added 2.56%	6,657 $718,000
Q2 2021 Jul 30, 2021	BUY	$105.21 - $117.21 $18,727 - $20,863	178 Added 2.82%	6,491 $637,000
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $1,125 - $1,238	11 Added 0.17%	6,313 $683,000
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $15,212 - $20,538	-189 Reduced 2.91%	6,302 $675,000
Q2 2020 Jul 21, 2020	SELL	$73.37 - $98.18 $733 - $981	-10 Reduced 0.15%	6,491 $637,000
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $6,450 - $9,779	100 Added 1.56%	6,501 $706,000
Q4 2019 Jan 31, 2020	SELL	$72.13 - $90.25 $30,871 - $38,627	-428 Reduced 6.27%	6,401 $567,000
Q3 2019 Oct 24, 2019	SELL	$62.98 - $75.72 $141,893 - $170,597	-2,253 Reduced 24.81%	6,829 $517,000
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $86,395 - $110,433	-1,315 Reduced 12.65%	9,082 $660,000
Q1 2019 Jun 12, 2019	SELL	$77.14 - $90.79 $191,692 - $225,613	-2,485 Reduced 19.29%	10,397 $22,000
Q4 2018 Jun 12, 2019	BUY	$77.85 - $96.01 $1 Million - $1.24 Million	12,882 New	12,882 $1.19 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Corp , based on Form 13F filings with the SEC.

News

Stay updated on First National Corp with notifications on news.

Account

First National Corp Abb Vie Inc. Transaction History